Skip to main content
. 2020 Aug 20;23(5):284–289. doi: 10.1016/j.cjtee.2020.08.006

Table 2.

Indicators and scores of BISCPM.

Indicators Scores (points)
0 1 2 3 4
A A1 A1-1 Movement Obeys Localized pain Withdrawal Abnormal flexion None
A1-2 Pupillary light reflex Bilateral normal Unilateral reflex Bilateral abnormal
A1-3 Pupil diameter Bilateral normal Unilateral myosis Bilateral myosis Unilateral mydriasis Bilateral mydriasis
A1-4 Hematoma volume (mL) ≤30 >30 >60 >90 >120
A1-5 Midline shift distance (cm) ≤0.5 >0.5 >1.0 >1.5 >2.0
A1-6 Ambient cistern width (mm) >3 ≤3 ≤1
A1-7 traumatic subarachnoid hemorrhage None Yes
A2 A2-1 High ICP (mmHg) <15 ≥15 ≥18 ≥22 ≥25
A2-2 Low BP (mmHg) >70 and < 110 ≤70 ≤55 ≤40 ≤25
A2-3 Hypertension (mmHg) >70 and < 110 ≥110 ≥130 ≥150 ≥170
A2-4 Low CPP (mmHg) >60 ≤60 ≤50 ≤40 ≤30
A2-5 High fever (°C) <38 ≥38 ≥39 ≥40 ≥41
A2-6 Hyperglycemia (mmol/L) <7.0 ≥7.0 ≥12.0 ≥17 ≥22
A2-7 Tachycardia (bpm) <120 ≥120 ≥130 ≥140 ≥150
A2-8 Hypoxemia (kPa) >8.0 ≤8.0 ≤7.0 ≤6.0 ≤5.0
A2-9 Hypernatremia (mmol/L) >130 and < 150 ≥150 ≥160 ≥170 ≥180
A2-10 Hyponatremia (mmol/L) >130 and < 150 ≤130 ≤120 ≤110 ≤100
A2-11 Hyperkalemia (mmol/L) >3.5 and < 5.5 ≥5.5 ≥6.5 ≥7.5 ≥8.5
A2-12 Hypokalemia (mmol/L) >3.5 and < 5.5 ≤3.5 ≤2.5 ≤1.5 ≤0.5
A2-13 HSCa (mg/100 mL) <1.5 ≥1.5 ≥2.5 ≥3.5 ≥4.5
B Age (years) 1 2 3 5 7 9
≤30 31–40 41–50 51–60 61–70 >70
C Medical history 0 3
None Chronic diseaseb

☆The total score is the sum of score of part A, B and C.

a

HSC: high serum creatinine.

b

The chronic diseases include: Cardio vascular system: New York Heart Association Class Ⅳ. Liver: biopsy proven cirrhosis and documented portal hypertension; prior episodes of hepatic failure, encephalopathy, or coma. Respiratory system: chronic restrictive, obstructive, or vascular disease resulting in severe exercise restriction; or documented chronic hypoxia, hypercapnia, secondary polycythemia, severe pulmonary hypertension (>40 mmHg), or respiratory dependency. Kidney: receiving chronic dialysis. Immuno-compromised: The patient has received therapy that suppresses resistance to infection, e.g., immune-suppression, chemotherapy, radiation, long term or recent high dose steroids, or has a disease that is sufficiently advanced to suppress resistance to infection, e.g., leukemia, lymphoma, AIDS.